Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

QuantHealth raises $45 million Series B led by Qumra Capital to enhance AI simulations in clinical trials. The funding will support R&D and workforce expansion.

PRIVATEAug 04, 2026•5 days ago

Amount Raised

$45 Million

Round Type

Series B

Tel AvivBiotechnologyHealth Careresearch

Investors

Esplanade VenturesShoni Top VenturesNew Health VenturesGc VenturesBertelsmann Healthcare Investments (Bhi)Artofin Venture Capital Fund L.P.Sanofi VenturesPitango Health TechQumra Capital

Description

QuantHealth, which develops AI-based simulations for clinical trials, has raised $45 million in a Series B funding round led by growth fund Qumra Capital. The latest round aims to expand its research and development capabilities and broaden its therapeutic coverage. Founded in 2020, QuantHealth employs approximately 85 people. The company is based in both New York and Tel Aviv.

Company Information

Company

QuantHealth

Location

8 הארבעה

Tel Aviv, Tel Aviv District, Israel

About

QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies. QuantHealth has one the largest integrated datasets that spans the clinical, pharmacological and biological domains together with a proprietary AI platform that can predict patient-response to both approved and novel therapies.

Related People

Suggested for you
1 contact
Verified contactsNo contacts on file at QuantHealth yet.
Predictive Intelligence
Strategic

ML-powered predictions for QuantHealth's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.